Tag Archives: Liver Specialists of Texas

Alcoholic Liver Disease: What You Need to Know-The Basics

Our latest video covers the basic aspects of alcohol related liver disease, and the complications of excessive alcohol intake. In general, there are three areas of concern: 1. The development of alcoholic fatty liver disease 2. The development of acute alcoholic hepatitis 3. Alcoholic cirrhosis The major point to understanding is that all alcoholic drinks […]

Comments { 0 }

New Hepatitis C Drug Approved: Janssen’s Hepatitis C Drug Simeprevir Now Available

This past week, the FDA gave approval to Janssen’s new drug to treat hepatitis C. Simeprevir, commercially know as OLYSIO, is the first new hepatitis C drug since the release of telapravir (Incevik) and boceprevir (Victrelis) in 2011. Simeprevir is a  NS3/4A protease inhibitor, used in combination with interferon and ribavirin. The release of simeprevir marks […]

Comments { 0 }

Dr. Joe Galati and the Liver Specialists of Texas Staff: Supporting Local Charities

Our practice, Liver Specialists of Texas and staff, have been supporters of the First Colony Dream League. The Dream League roster is approximately 60 physically- and/or mentally- challenged players. In addition, the league has an “Angels in the Outfield” program, where approximately 150 teenage boys and girls from Ft. Bend area schools volunteer to assist […]

Comments { 0 }
Lentils: A Super Food to Love

Lentils: A Super Food to Love

Day 20. Hard to believe we are almost finished with the 31 Days of Wellness. Don’t fear, there are 334 days in the year left afterwards. There is a very nice entry from the New York Times Recipe for Health section, that features an assortment of healthful recipes you should all bookmark and check in […]

Comments { 0 }

Dr. Joe Galati Discusses Colonoscopy: Instructions for our Patients

Comments { 0 }

Dr. Galati and Liver Specialists of Texas: What We Do

We have produced a brief introductory video describing the staff and activities of Liver Specialists of Texas.  Let us know what you think. Your feedback is valued.

Comments { 1 }

Dr. Saira Khaderi Discusses Hepatology

Comments { 0 }
Boceprevir is FDA Approved:Now What?

Boceprevir is FDA Approved:Now What?

Now that Boceprevir is FDA approved, it seems that a big sigh of relief has been let out by both patients and physicians. Despite this great news and FDA success, the work now starts, evaluating and screening the thousands of patients that have been waiting for this day. Here is my advice to all concerned […]

Comments { 0 }
Telaprevir and FDA Approval: The Race is On for New Hepatitis C Drugs

Telaprevir and FDA Approval: The Race is On for New Hepatitis C Drugs

For those of us that are involved in the care of patients with chronic hepatitis C, the “never too soon” announcement that we will finally have new drugs to treat our hepatitis C patients with cannot come soon enough. There is a real possibility that one and possibly two new agents for hepatitis C will […]

Comments { 69 }
The MELD Score and Liver Transplant: An Update for Patients

The MELD Score and Liver Transplant: An Update for Patients

Patients awaiting transplant commonly have questions regarding there MELD score, and how this number is determined. As you can imagine, there is great anxiety in patients awaiting transplant. At almost every clinic visit, patients are asking for they’re updated score. In my own practice, at every visit we calculate the new score and discussed this result with […]

Comments { 55 }